Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
AstraZeneca
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Complement Theory Inc.
City of Hope Medical Center
NeoTX Therapeutics Ltd.
Memorial Sloan Kettering Cancer Center
Pfizer
Institute of Cancer Research, United Kingdom
Massachusetts General Hospital
Vanderbilt-Ingram Cancer Center
Eli Lilly and Company
University of Alabama at Birmingham
University College, London
Memorial Sloan Kettering Cancer Center
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Memorial Sloan Kettering Cancer Center
Agenus Inc.
Carisma Therapeutics Inc
University of Toronto
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc